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Abstract
Background: Gallstone disease and chronic calculous cholecystitis are the most prevalent gastro-enterological diseases requiring a surgical treatment. 
This disease occupies a special place in the pathology of the hepato-bilio-pancreatic area, which is important for the etiological diagnosis as well as for the 
resonance and the complex impact on the function of the adjacent organs. Besides, gallstone disease can result in serious outcomes, such as acute gallstone 
pancreatitis and gallbladder cancer. This article analyzes the clinico- morphological characteristics of gallbladder stones. At the same time, the role of 
duodenal dysmotility in the ethiopathogenesis of cholestasis was reevaluated through the contemplation of the contemporary concepts of lithogenesis.
Conclusions: The pathogenesis of gallstone disease is suggested to be multifactorial and probably develops from complex interactions between many 
genetic and environmental factors and the state of adjacent organs. Based on its anatomical and physiological features, the duodenum is a completely 
unique crossroads where the digestive pathways of the stomach, liver and pancreas meet. The sealing functionality of these organs allows them to be 
cataloged as an integral system, and the duodenum due to its specific role exerts ”the pituitary function” of the gastrointestinal tract. Therefore, any 
disruption of the duodenum activity may not be etiopathogenetically reflected on the hepatobiliary-pancreatic disease, and biliary cholelithiasis is no 
exception in this regard. The achievement in the study of the pathophysiology of bile stones formation and the pathogenesis of gallstone disease can help 
to improve the complex medico-surgical treatment of this category of patients.
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Introduction
Vesicular cholelithiasis (VC) is a plurifactorial patholo-
gy (with intrinsic and extrinsic mechanisms) characterized 
by disruption of the properties of gall-particle dispersion 
associated with agglomeration, aggregation and formation 
of bile calculi, – a starting point for the evolution and persis-
tence of chronic inflammation of the bladder wall. The dis-
ease occupies a special place in the pathology of the hepato-
bilio-pancreatic area, which is important for the etiological 
diagnosis as well as for the resonance and the complex im-
pact on the function of the adjacent organs.
At present, the etiopathogenetic aspects of vesicular 
cholelithiasis in males are unclear [1-6]. Therefore, it would 
be logical and legitimate to suppose that the evolution of 
VC in men requires the presence of mechanisms of another 
nature, or the accentuation of the already known phenom-
ena, which at the moment are arbitrarily assigned a second-
ary, complementary role. This assumption is also admitted 
as possible in the development of vesicular cholelithiasis in 
children (in the Republic of Moldova with an incidence of 
1197 cases per 10000 population, in the USA – 1% in girls, – 
0.4% in boys, [7]), where the sex hormone-dependent etio-
pathogenetic factor is totally excluded [8-10].
In this context, the following question seems reasonable. 
Why it is the role of common etiopathogenetic links, al-
ready known (apparently “less” complex) is underestimated 
or neglected in the evolution of vesicular cholelithiasis and 
recognized in clinical practice as secondary factors? In our 
opinion, this is a consequence of the education of a specific 
medical mentality, formed over the decades, of a state of 
conduct that allows a certain degree of simplistic attitude to 
the canons of human general pathologies, explicitly formu-
lated by academics Sarkisov D.S. and Paliţev M.A. in 1995 
[11]:
– if the chronic evolution of the condition is conditioned 
solely by the change of the «causal-determinant» rela-
tionship and is not dependent on the cause, the treat-
ment should be addressed specifically to the causal fac-
tor;
– since some factor has contributed to the initiation of the 
disease and has not lost its value over time and contin-
ues to maintain it, then it needs to be included in the 
field of medical action.
Currently, when it comes to VC risk factors in men, so-
called abdominal obesity is considered, which contributes 
to increased intra-abdominal pressure and motor disorder 
not only of the gastrointestinal tract, but also of the gall 
bladder, type I diabetes, insulin resistance diabetes melli-
tus), metabolic syndrome, biliary sludje of various etiology, 
liver cirrhosis [12-16].
At the same time, the latest scientific publications pay at-
tention to the role of dysfunctional duodenal motility in the 
etiopathogenesis of VC, overlooking this important etio-
pathogenetic link, or simply limiting itself to finding the lat-
ter in the cholecystectomized patient [17-20]. We consider 
this unjustified simplistic approach, having the tendency to 
bring some perceptions based on the bibliographic sources 
analyzed and estimated by the contemplation of the con-
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temporary concepts of biliary lithogenesis and the reevalu-
ation of the etiopathogenetic role of the gastro-duodenal 
dismotility in the formation of bile calculi.
Composition of gallstones. Analysis of the literature 
shows a certain connection between the characteristics of 
bile stones and sex. It is known that 3 types of base [13, 21-
23] of the calculus are specified according to the cholesterol 
composition. In connection with the detection frequency, 
overwhelming majority of cholesterol is detected (choles-
terol ≥ 70%), mixed (30% ≥70% cholesterol) and pigments 
(30% ≥ cholesterol). However, the composition of bile cal-
culi did not attract adequate attention in current studies 
conducted on investigated population cohorts, probably 
due to the need to use laborious and costly techniques (in-
frared transformation spectrometry) and clinical practice is 
limited to visual inspection [24-27]. On the other hand, the 
study of the compositional structure with the homogeneity 
analysis is important because it directly reflects the mecha-
nisms of constitution, as follows: a) cholesterinic calculi are 
characteristic of the dyslipidemia processes [28-31], while 
the pigments or mixed ones indicate the prevalence gall-
bladder stasis mechanisms with excessive absorption of bile 
salts, with significant differences in hydration degree and 
dispersant level of constituents [30,32-34].
Various researches indicated that pigment calculi pos-
sess a constitutive element «microbial center», determined 
by bacterial colonization [21,38,42] (mainly Helicobacter 
subspecies, but not Helicobacter pilory proper) - it is yet 
another «force» reasoning in favor of the gallbladder con-
gestion hypothesis as well as duodenal-biliary reflux on the 
background of duodenostasis as well as the etiopathogenet-
ic role of the gastrointestinal tract microbe in the evolution 
of biliary cholelithiasis [35-37].
Some authors denote a high proportion of cholesterol 
bile calculi in the latest investigations, cholesterol (95%), 
bilirubin (30%), and calcium (10%) [21, 22, 24, 29]. Rare 
components include palmitate / stearate, polysaccharides 
and protein substances. In contrast, research in the 1960s 
and 1970s showed the prevalence of pigment build-ups 
within 23-30 percent of observations. These statistical un-
certainties can be caused either by the absence of age-related 
randomization in the investigated cohorts or by westerni-
sation of the society, which also lead to an increase in the 
prevalence of cholesterol bile calculi among susceptible 
populations.
Pigmentation calculations are divided in turn into black 
ones (compact and small) and brown (softer and bigger). 
Pigmentation stones account for about 20% of vesicu-
lar calculi and are more common in the elderly. They are 
mainly composed of calcium bilirubinates, phosphates and 
carbonates without any cholesterol impurity [23, 36, 37]. 
Brown ones are mainly located in the bile duct and amount 
to about 10% of the total number of calcium bilirubinates 
less polimerized than black pigments, such as cholesterol 
and palmitate or calcium stearate. So in the case of pigment 
stones the over-saturation of the bile with unconjugated bil-
irubin plays an important role, leading to physico-chemical 
changes of the bile with the expression of agglomeration 
and crystallization processes [38,39]. This explains the fact 
that intrahepatic calculi contain high levels of free bile acids 
deconjugated by glycine and taurine by intestinal bacterial 
agents involved in the etiopathogenesis of VC.
Therefore, the evolution of dysfunctional duodenal mo-
tility leads directly to the amplification of synthesis processes 
of bile acids deconjugated with their subsequent absorption 
and the increase in blood bed concentration. The biochemi-
cal investigations of these stones have demonstrated a high 
level of saturated free fatty acids as well as the involvement 
of phospholipases that decompose bile phospholipids, par-
ticularly phospholipase A1 [29,40,41].
Pure calcined gallstones, exclusively composed of calci-
um carbonate, are very rare in adults [42-44], whereas they 
are relatively common in children [45], with a mucin hyper-
secretion produced by the gallbladder epithelial cells into 
obstruction of the cystic duct.
Mixed calculi, cholesterolo-pigmented are most freely 
detected, possess a lamellar structure and are different in 
shape and size. The causes and factors that induce the al-
ternation of layers and their chemical heterogeneity remain 
unknown. Data obtained by electronic microscopic scan 
suggests that the composition and structure of mixed soli-
tary or multiple calculi is different [46,47]: (1) the solitary 
stones display a protein-cholesterol-nucleus composition; 
(2) the multiple stones denote nucleic protein-bilirubin 
composition; and (3) additionally, both contain a protein 
component disposed along the sectional plane. Whether or 
not bile glycoproteins are involved in cholesterol formation 
is currently a subject of discussion. The data of the qualita-
tive and quantitative biochemical research of the mucinous 
glycoprotein protonic activity is at the moment contradic-
tory and uncertain [48].
Knowledge of the chemical, structural and component 
composition of gallbladder stones is essential to under-
standing the VC etiopathogenesis. In order to identify the 
predisposing factors, X-ray diffraction analysis, atomic ab-
sorption spectroscopy and various biochemical estimates 
were performed [8,48-51]. The elemental analysis records 
the primary role of calcium as the major constituent ele-
ment, complemented by iron, magnesium and zinc [2,52].
Patients with VC are exposed to growth of total plasma 
bilirubin and conjugated bilirubin levels, as well as liver 
function parameters (glutamic pyruvic transaminases, oxa-
lo-acetic acid transaminases and alkaline phosphatase). 
Higher concentrations of malondialdehyde are found, sig-
nificantly escalating the glutathione disulfide / glutathio-
ne ratio, essentially decreasing the activity of antioxidant 
enzymes (superoxide dismutase, catalase and glutathione 
peroxidase) compared to patients without VC [19,48]. Fur-
ther studies are needed to determine whether the observed 
differences are a cause or effect of calculi formation [8,46]. 
These studies could eventually result in the development of 
new medical-surgical strategies for the treatment of vesicu-
lar cholelithiasis, providing useful information from the as-
pect of drug prophylaxis of VC relapse [47, 54, 55]. 
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Analyzing the available literature, we mention a very 
small number of studies, which would refer to the morpho-
clinical, etiopathogenetic particularities of VC performed 
exclusively in men [2,4,5].
At the same time, in the researches, based on mixed 
samples of the population, it is indicated that male individ-
uals affected by cholelithiasis are characteristic in the vast 
majority of cases of pigment calculi [47,56,57], as with clini-
cal observations of recurrence or evaluation of the primary 
choledocolithiasis [58-60].
Thus, Schafmayer C. et al. (2006) [47], analyzing 1025 
observations of VC with the study of biliary calculus com-
position by means of spectro-electron microscopy, showed 
that pigments (small in size and an average weight of 0.6g) 
were detected in 58% of the cases, in 38% of the cases were 
mixed cholesterol-biliary calculi, while women predomi-
nated in cholesterol-based calculi with an incidence of 95%. 
There is not only a direct interrelation between the sex and 
the calculus structure, but it is also found that men up to 
the age of 40 have a uniform distribution of the ratio of cho-
lesterinic / pigmentary calculi, whereas in the age group of 
over 40 the pigmentation predominates totally [4,5].
By making a simple analogy, we can deduce that in men 
the formation of calculi is largely determined by the pro-
cesses of stinging the bile (bile congestion with its composi-
tional changes), regardless of the causative-determinant fac-
tor of the bile stasis, although the role can not be completely 
denied disorders of cholesterol metabolism, thus there is a 
way of «symbiosis» of etiopathogenetic mechanisms, which 
mutually amplify. This hypothesis in our opinion explains to 
some extent the following phenomena observed in everyday 
clinical practice:
– a higher rate of evolution of acute cholecystitis in men, 
relative to the number of men carrying calculi, with all of 
these negative repercussions (intraoperative technical diffi-
culties, impossibility of subsequent laparoscopic cholecys-
tectomy resulting in a higher number of conversions, slower 
postoperative recovery, negative economic effect and so on);
– relatively sudden onset of clinical manifestations in 
young male subjects, with a rather rapid progress in the 
clinical picture; the time “addressing- surgical treatment” 
is broadly explained by the reduced dimensions of the 
pigment calculi compared to the cholesterol, so a greater 
“chance” of closing the cystic channel with the triggering 
of the acute inflammatory process; either by migrating the 
microcalculators through the extrahepatic bile ducts with 
their “irritation” → spasm reflector → biliary hypertension → 
progression of the inflammatory process;
– as a rule, in older males the clinical picture does not 
differ essentially from that which evolves in women, allow-
ing for pre-operative pre-treatment according to somatic 
status and compensation of concomitant diseases with the 
approach of expectative-active tactics, – the fact that with 
age, appears a deficiency of enzymes responsible for metab-
olism of cholesterol, as a possible explanation, the constitu-
tive mechanism is similar to the evolution of VC in women; 
a more thorough anamnesis may well indicate that we have 
the same period of “illness-addressing-treatment”;
Of course, these personal findings are not devoid of sub-
jective factors (health culture of the population, different 
in men and women, more frequent imaging examinations 
in women and a higher rate of detection of asymptoma-
tic “silent” calculi, general aging of the population; for our 
country there is also a “specific” factor, conditioned by the 
massive migration of people able to work, and thus dispro-
portionality in relation to age groups, etc.) and are questio-
nable, require scientific argumentation and confirmation.
Literature data show that about 2-12% of patients deve-
lop acute cholecystitis [61,62], the first case being described 
by Duncan J. in 1844 [63]. From a histological point of view, 
the evolution of the inflammatory process in the gallblad-
der does not differ as compared to acute VC [37,41], which 
was also confirmed in experimental research [64]. Accord-
ing to the illustrious surgeons and eminent savants Cuzin 
M.I. [65], Şalimov A.A. [66] the pathological phenomenon 
initially behaves aseptically in the presence of biliary pas-
sage disorders (neurovegetative disorders with dismotility), 
subsequently associating the infectious factor, the primary 
role being the obstruction of the bile flow. At the same time, 
the vast majority of authors attributed the role of primary 
etiologic factor in acute cholecystitis to the motor disorders 
of the digestive tract, statistically demonstrating a definite 
higher rate of male illness compared to women (with a sig-
nificant prevalence of the male gender of about 3-4 times) 
[46, 47].
Thus, we can conclude that a potential etiologic factor 
of vesicular cholelithiasis in males is the state of the neu-
ro-vegetative system, the activation of its parasympathetic 
component with the dysfunction of the gastrointestinal 
tract motility [46,67,68]. This finding seems to be reflected 
in the results of other authors [69-72]. Thus, Rîjcova O.V. 
[73] denotes the state of activation of the sympathetic sys-
tem in women with VC, and vice versa, in male vesicular 
cholelithiasis is associated with vagotonia and an exacer-
bation of parasympathetic neurovegetative component. 
Assessed from this point of view, the etiopathogenicity of 
biliary calculi formation in males suggests the possibility of 
indirect effects of suprasegmental components of the auto-
nomic nervous system directly on biliary tract motility by 
modulating the regulation of sympathetic-parasympathetic 
activity.
An argument in this regard is also the fact that there is 
a frequent association of vesicular cholelithiasis with ulce-
rative disease, which ranges from 11-34% [75,78], and ac-
cording to some authors it exceeds more than half of the 
total number of cases of combined diseases [74]. In this con-
tingent of patients, biliary dysfunction is reported in about 
54%, predominantly in the hypotonic state of the gallblad-
der (72%) [68,75].
Multiple studies indicate the presence of duodeno-
stomachal reflux in patients with vesicular cholelithiasis. 
The incidence of these symptoms varies between different 
authors from 2.6% to 80%, and although several hypotheses 
have been proposed, the cause remains unknown [76,77]. 
Some attribute to it a defensive pathophysiological func-
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tion, aimed at reducing the acidification of the duodenum, 
while recognizing that the duodeno-stomachal reflux is also 
characteristic of healthy people [78]. Conversely, others dis-
pute this view by taxing the alkalization of the stomach as 
a responsible for reducing the gastric motility [70,71], its 
functional loss in a humoral aspect evolved from processes 
of either hypotrophic nature or determined by metastatic 
or dysplastic phenomena of the anthrum mucosa under the 
action of bile salts [79,80].
At present, the role of duodenal gastric reflux in patients 
with VC is not defined and requires specification. Finally, 
the evolution of the duodenal gastric reflux in the VC di-
rectly reflects the occurrence of anthro-duoodenal region 
contraction disturbances, the increase of intraduodenal 
pressure through fluid accumulation, the duodenal wall 
distension, and indirectly signals the initiation of a hypox-
ic and nutritional stress of the duodenal mucosa resulting 
from disturbances at the level of micro-circulation within 
the duodenostasis.
It is well known that the gallbladder evacuation motor 
function is dependent on the gastrointestinal migratory 
myoelectric complex (MMC) and particularly correlates 
with the functional state of the duodenum [43]. The inte-
gral MMC activity is ensured by neuro-humoral factors, 
and propulsive pacemakers are Cajal cells, located mainly 
in the antral part of the stomach, duodenum and ileo-cecal 
angle. The Cajal cells along with plex neurons Auerbach 
and Meissner coordinate the synchronization of the motor 
movements of the anthro-duodenal region, and are directly 
responsible for the proper passage of the bile duct into the 
duodenal lumen.
Moreover, there is a disruption of the secretion of hu-
moral factors (especially the cholecystokinin - the «main 
orchestrant of bladder and bile duct motility», YY peptide, 
gastrin, secretin, diminishing of the number of specific re-
ceptors) [8,55,80], a consequent secretion of proinflamma-
tory cytokines (IL-1, IL-6, TNF-α) and vasoactive remedies 
(prostaglandins, nitric oxide) [81,82], that mediate dysfunc-
tion of intestinal muscle contraction, aggravating in this 
sense duodenostasis [83,84].
In turn, TNF-a activates the leukocyte chemotaxis, the 
monocytes accelerate their migration processes into the 
bladder wall, leading to inflammation, edema, and desqua-
mation of the mucosal epithelium of the gallbladder [80,85]. 
Processes of atrophy and sclerosis of the bladder wall evalu-
ate gradually, essentially disrupted by its absorption, se-
cretory and motor functions. Moreover, atrophic sclerotic 
processes have a direct impact on the number of sensitized 
receptors to cholecistokinin produced by endotheliums of 
the duodenum, thus further exacerbating the gallbladder 
hypomotility.
At the same time, one of the factors contributing to the 
overproduction of cytokines in the pathophysiological as-
pect is ischemia, both macro- and microcirculatory, as well 
as that of tissue, so the duodenostasis represents an impulse 
to modify the immune system (immunosuppression) and 
especially cytokine secretion pro-inflammatory as first-line 
mediators. Thus, the duration of the intestinal wall ischemia 
and subsequent production of TNF-α and IL-6, cytokin-
emia being favored concurrently by the presence of «out of 
control» bacterial colonies. Disorders of autonomic neuro-
nal intestinal reflexes in turn reduce the sensory extension 
of the stomach and duodenum, thereby contributing to ag-
gravation of duodenostasis with tissue ischemic changes 
[83], as a mirroring activity is induced and a dismotility of 
the subadditive intestinal segments.
The hypomotor state of the gastrointestinal tract de-
termines the microbial modification and essential growth 
of microbial flora and its metabolic products in the small 
intestine, - the phenomenon of enteric colonization with 
exacerbation of flora activity and microbial hypersensitivity 
of secondary bile acids (especially deoxycholic) followed by 
their absorption into the portal bed [1,70,71,82].
As a result, the deterioration of the enterohepatic cycle 
of biliary metabolism increases with the increase in the hy-
drophobic bile acid ratio, which in turn is the cause of the 
lithogenic characteristics of the bile. Viewed as a whole, the 
triggering of the above-mentioned mechanisms potentiates 
the unfavorable effects, constituting the creation of a «circle 
vicious», the elements of which possess a cumulative char-
acter and mutual potentiation [21,35,55].
Summarizing the literature data, we conclude on the 
important role of the duodenum in the evolution of biliary 
lithiasis, a concept that remains the subject of permanent 
discussion, with all its arguments and contradictions, but 
Fig. 1.  The scheme of etiopathogenesis of vesicular cholelithiasis 
evaluated in connection with the functional state of the 
duodenum.
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still completely unresolved at present. In our schematic 
view, some mechanisms of etiopathogenesis of cholelithia-
sis evaluated in terms of disorders of duodenal functionality 
can be ranked in the following scheme.
Conclusions
Based on its anatomical and physiological features, the 
duodenum is a completely unique crossroads where the di-
gestive pathways of the stomach, liver and pancreas meet. 
The sealing functionality of these organs allows them to be 
cataloged as an integral system, and the duodenum due to 
its specific role exerts the pituitary function of the gastro-
intestinal tract. Therefore, any disruption of the duodenum 
activity may not be etiopathogenetically reflected on hepa-
tobiliary-pancreatic disease, and biliary cholelithiasis is no 
exception in this regard.
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